(19)
(11) EP 4 581 051 A1

(12)

(43) Date of publication:
09.07.2025 Bulletin 2025/28

(21) Application number: 23776546.6

(22) Date of filing: 31.08.2023
(51) International Patent Classification (IPC): 
C07K 16/10(2006.01)
A61P 31/14(2006.01)
A61K 39/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/10; C07K 2317/569; C07K 2317/22; C07K 2317/24; C07K 2317/565; A61P 31/14
(86) International application number:
PCT/US2023/073213
(87) International publication number:
WO 2024/050457 (07.03.2024 Gazette 2024/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 31.08.2022 US 202263402839 P

(71) Applicant: Boost Biopharma, Inc.
Woburn, MA 01801 (US)

(72) Inventors:
  • SCHOMBURG, Fritz M.
    Madison, Wisconsin 53713 (US)
  • RANCOUR, David M.
    Madison, Wisconsin 53713 (US)

(74) Representative: Maiwald GmbH 
Elisenhof Elisenstraße 3
80335 München
80335 München (DE)

   


(54) SARS-COV-2 BINDING AGENTS AND USES THEREOF